Citigroup’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $160K | Sell |
|
|||||
|
2025
Q2 | $4.96M | Sell |
|
|||||
|
2025
Q1 | $3.33M | Buy |
|
|||||
|
2024
Q4 | $362K | Buy |
|
|||||
|
2024
Q3 | $570K | Buy |
|
|||||
|
2024
Q2 | $91.2K | Buy |
|
|||||
|
2024
Q1 | $64.2K | Buy |
|
|||||
|
2023
Q4 | $51.6K | Buy |
|
|||||
|
2023
Q3 | $39.7K | Sell |
|
|||||
|
2023
Q2 | $130K | Buy |
|
|||||
|
2023
Q1 | $6.75K | Sell |
|
|||||
|
2022
Q4 | $12.7K | Sell |
|
|||||
|
2022
Q3 | $14K | Sell |
|
|||||
|
2022
Q2 | $21K | Buy |
|
|||||
|
2022
Q1 | $29K | Sell |
|
|||||
|
2021
Q4 | $147K | Buy |
|
|||||
|
2021
Q3 | $176K | Buy |
|
|||||
|
2021
Q2 | $96K | Buy |
|
|||||
|
2021
Q1 | $69K | Sell |
|
|||||
|
2020
Q4 | $110K | Buy |
|
|||||
|
2020
Q3 | $41K | Sell |
|
|||||
|
2020
Q2 | $107K | Buy |
|
|||||
|
2020
Q1 | $83K | Buy |
|
|||||
|
2019
Q4 | $67K | Buy |
|